↓ Skip to main content

Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil

Overview of attention for article published in Journal of Law, Medicine & Ethics, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#22 of 977)
  • High Attention Score compared to outputs of the same age (98th percentile)

Mentioned by

news
4 news outlets
twitter
35 tweeters
facebook
8 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil
Published in
Journal of Law, Medicine & Ethics, January 2021
DOI 10.1111/j.1748-720x.2012.00698.x
Pubmed ID
Authors

Lucija Tomljenovic, Christopher A. Shaw

Abstract

There are not many public health issues where views are as extremely polarized as those concerning vaccines, and Merck's HPV vaccine Gardasil is a case in point. Ever since gaining the FDA's approval in 2006, Merck has been heavily criticized for their overly aggressive marketing strategies and lobbying campaigns aimed at promoting Gardasil as a mandatory vaccine. Subsequently, questions have been raised as to whether it was appropriate for vaccine manufacturers to partake in public health policies when their conflicts of interests are so obvious. Some of their advertising campaign slogans, such as "cervical cancer kills x women per year" and "your daughter could become one less life affected by cervical cancer," seemed more designed to promote fear rather than evidence-based decision making about the potential benefits of the vaccine. Although, conflicts of interests do not necessarily mean that the product itself is faulty, marketing claims should be carefully examined against factual science data. Currently Gardasil vaccination is strongly recommended by the U.S. and other health authorities while public concerns about safety and efficacy of the vaccine appear to be increasing. This discrepancy leads to some important questions that need to be resolved. The current review examines key issues of this debate in light of currently available research evidence.

Twitter Demographics

The data shown below were collected from the profiles of 35 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Turkey 1 1%
Canada 1 1%
Unknown 79 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 24%
Student > Master 15 18%
Researcher 10 12%
Student > Ph. D. Student 10 12%
Student > Doctoral Student 7 8%
Other 14 17%
Unknown 7 8%
Readers by discipline Count As %
Medicine and Dentistry 25 30%
Agricultural and Biological Sciences 12 14%
Nursing and Health Professions 11 13%
Social Sciences 8 10%
Biochemistry, Genetics and Molecular Biology 5 6%
Other 12 14%
Unknown 10 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2020.
All research outputs
#407,838
of 16,710,634 outputs
Outputs from Journal of Law, Medicine & Ethics
#22
of 977 outputs
Outputs of similar age
#2,712
of 152,259 outputs
Outputs of similar age from Journal of Law, Medicine & Ethics
#1
of 1 outputs
Altmetric has tracked 16,710,634 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 977 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,259 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them